Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801488 · ClinicalTrials.gov registry record
Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- 5
- Enrollment target
NCT01801488 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 5 participants.
The verdict
NCT01801488 was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
Test single nucleotide polymorphisms (SNP's) in ruptured and unruptured aneurysm tissue to identify a genetic difference between the two types of aneurysms; and to test SNP's in arteriovenous malformation tissue to identify a genetic link.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01801488
The ClinicalTrials.gov registry entry for NCT01801488 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01801488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01801488 about?
NCT01801488 is a clinical study titled "Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm". Test single nucleotide polymorphisms (SNP's) in ruptured and unruptured aneurysm tissue to identify a genetic difference between the two types of aneurysms; and to test SNP's in arteriovenous malformation tissue to identify a genetic link.
What is the current status of trial NCT01801488?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2011-11.
Who is sponsoring clinical trial NCT01801488?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.